Soft part sarcomas--metastases.
Pulmonary metastases may be resected safely with associated long-term survival. Regardless of histology, complete resection is associated with improved survival in most series. Various prognostic indicators may help clinicians select the optimal treatment for patients with pulmonary metastases. Novel treatment methods such as regional drug delivery or genetic manipulation may further enhance disease-free and overall survival.
Putnam
J B
JB
Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, USA.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D010478:Chemotherapy, Cancer, Regional Perfusion; D015316:Genetic Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D009364:Neoplasm Recurrence, Local; D010166:Palliative Care; D018579:Patient Selection; D011013:Pneumonectomy; D011379:Prognosis; D012509:Sarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D015996:Survival Rate; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents